Sign inJoin waitlistJoin the waitlist

TW

Tina Wood

Credentials: · ·

History

Hematology and Medical Oncology
University of Alabama at Birmingham
2002–2005
Internal Medicine
1999–2002
Wake Forest Univ Sch of Med
1995–1999

Research

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial
Journal of Clinical Oncology · 2011 · 883 citations
Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5)
Cancer Biotherapy and Radiopharmaceuticals · 2010 · 127 citations
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients…
Annals of Oncology · 2016 · 93 citations

DH
Daniel Von Hoff
2 papers
JP
James Posey
2 papers
Martin Heslin
2 papers
RR
Ramesh Ramanathan
2 papers
AF
Andres Forero-Torres
1 paper
Andrew Ko
1 paper
Andrew McDonald
1 paper · 1 as a resident
Anirban Maitra
1 paper
CD
Caleb Dulaney
1 paper · 1 as a resident
Christos Vaklavas
1 paper · 1 as a resident
Daniel Laheru
1 paper
EC
Elena Chiorean
1 paper